Exane BNP Paribas upgraded Ametek (AME) to Outperform from Neutral with a $210 price target Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and ...

Exane BNP Paribas downgraded Sodexo (SDXAY) to Underperform from Neutral with a EUR 68 price target The firm says the company’s employee layoffs challenge the assumption of a Q2 improvement ...

Exane BNP Paribas upgraded Adobe Inc. (NASDAQ:ADBE) to Neutral from Underperform and raised the stock's price target to $425. The analyst views better risks and rewards consideration on Adobe for its ...

Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for Novo Nordisk A (OTCPK:NONOF) from Neutral to Outperform. Analyst Price Forecast Suggests 2.43% Downside As of ...

Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for DKSH Holding (OTCPK:DKSHF) from Neutral to Outperform. Analyst Price Forecast Suggests 21.17% Upside As of May ...

UBS Group AG shares rose the most in two months as analysts at BNP Paribas Exane recommended buying on expectations the Swiss lender will increase share buybacks. The stock gained as much as 3.8% ...

(Bloomberg) -- UBS Group AG shares rose the most in two months as analysts at BNP Paribas Exane recommended buying on expectations the Swiss lender will increase share buybacks. The stock gained as ...

Digital-asset prime brokerage firm FalconX has acquired Arbelos Markets, a derivatives startup launched in 2023 by two crypto industry veterans. Terms of the transaction weren’t disclosed.

Key Laboratory of Chemical Biology of Fujian Province, iChEM, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, Fujian 361005, China Key Laboratory of Chemical Biology of ...

Fintel reports that on December 16, 2024, Exane BNP Paribas upgraded their outlook for Equifax (NYSE:EFX) from Neutral to Outperform. As of December 3, 2024, the average one-year price target for ...

"We see these results as a potential strong positive catalyst for the stock where the company will outline positive flows in Q3 and beyond and positive fund performance momentum,” it said.

Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for flatexDEGIRO (OTCPK:FNNTF) from Neutral to Outperform. As of March 27, 2023, the average one-year price target ...